RxDoctor Payments Data

David Cummin, MD

Family Medicine · Logan, OHNPI 1295724359

Payments from drug & device makers

$13,648in general payments, 2019–2025

Across 1,066 payments — averaging $12.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • AbbVie$1K
  • GSK$1K
  • Amgen$955
  • AstraZeneca$864
  • Pfizer$816
  • plus $6K from 44 others

What the payments were for

  • Food & beverage$13,39198%
  • Education$2562%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$13,648 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$138,547
Medicare patients
237
Services billed
6,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide257$322,598
EliquisApixaban144$166,443
Tresiba Flextouch U-200Insulin Degludec125$140,547
JardianceEmpagliflozin45$57,418
EntrestoSacubitril/Valsartan54$51,130
TrulicityDulaglutide36$50,811
XareltoRivaroxaban42$38,104
Janumet XrSitagliptin Phos/Metformin Hcl34$34,755
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$33,623
KerendiaFinerenone42$29,346
MounjaroTirzepatide19$26,780
MyrbetriqMirabegron40$25,674
Repatha SureclickEvolocumab21$20,953
OxycontinOxycodone Hcl25$18,370
JanumetSitagliptin Phos/Metformin Hcl21$16,532

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$2,544$322,598257 claims
PfizerEliquis$816$166,443144 claims
Lilly USA, LLCTrulicity, Mounjaro$303$77,59155 claims
Boehringer IngelheimJardiance, Jentadueto Xr$275$63,81757 claims
MerckJanumet Xr, Janumet$812$51,28755 claims
NovartisEntresto$334$51,13054 claims
Johnson & JohnsonXarelto$364$38,10442 claims
GSKTrelegy Ellipta$1,038$33,62338 claims
BayerKerendia$418$29,34642 claims
Astellas Pharma US IncMyrbetriq$311$25,67440 claims
AstraZenecaBrilinta$864$5,10912 claims
Sanofi-aventis U.S. LLCLantus$396$3,82120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Logan

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →